Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Dementia Drugs market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Dementia Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Dementia Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Sanofi SA
Merck & Co, Inc
Janssen Pharmaceuticals, Inc
Novartis AG
Valeant Pharmaceutical International
F. Hoffmann-La Roche
Eli Lilly and Company
Sanofi S.A
Merck & Co., Inc
AstraZeneca GmbH
Teva Pharmaceuticals Industries
Forest Laboratories, Inc
Pfizer Inc
By Type:
MAO Inhibitors
Cholinesterase Inhibitors
Glutamate Inhibitors
By End-User:
Glutamate Inhibitors
Glutamate Inhibitors
Glutamate Inhibitors
Glutamate Inhibitors
By Region:
-
Hokkaido
-
Tohoku
-
Kanto
-
Chubu
-
Kinki
-
Chugoku
-
Shikoku
-
Kyushu
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Dementia Drugs Market
-
1.3 Market Segment by Type
1.3.1 Japan Dementia Drugs Market Size and Growth Rate of MAO Inhibitors from 2014 to 2026
1.3.2 Japan Dementia Drugs Market Size and Growth Rate of Cholinesterase Inhibitors from 2014 to 2026
1.3.3 Japan Dementia Drugs Market Size and Growth Rate of Glutamate Inhibitors from 2014 to 2026
-
1.4 Market Segment by Application
1.4.1 Japan Dementia Drugs Market Size and Growth Rate of Glutamate Inhibitors from 2014 to 2026
1.4.2 Japan Dementia Drugs Market Size and Growth Rate of Glutamate Inhibitors from 2014 to 2026
1.4.3 Japan Dementia Drugs Market Size and Growth Rate of Glutamate Inhibitors from 2014 to 2026
1.4.4 Japan Dementia Drugs Market Size and Growth Rate of Glutamate Inhibitors from 2014 to 2026
-
1.5 Market Segment by Regions
-
1.5.1 Hokkaido Dementia Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Tohoku Dementia Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Kanto Dementia Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Chubu Dementia Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.5 Kinki Dementia Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.6 Chugoku Dementia Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.7 Shikoku Dementia Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.8 Kyushu Dementia Drugs Consumption Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Dementia Drugs Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Dementia Drugs by Major Types
3.4.1 Market Size and Growth Rate of MAO Inhibitors
3.4.2 Market Size and Growth Rate of Cholinesterase Inhibitors
3.4.3 Market Size and Growth Rate of Glutamate Inhibitors
4 Segmentation of Dementia Drugs Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Dementia Drugs by Major End-Users
4.4.1 Market Size and Growth Rate of Dementia Drugs in Glutamate Inhibitors
4.4.2 Market Size and Growth Rate of Dementia Drugs in Glutamate Inhibitors
4.4.3 Market Size and Growth Rate of Dementia Drugs in Glutamate Inhibitors
4.4.4 Market Size and Growth Rate of Dementia Drugs in Glutamate Inhibitors
5 Market Analysis by Regions
-
5.1 Japan Dementia Drugs Production Analysis by Regions
-
5.2 Japan Dementia Drugs Consumption Analysis by Regions
6 Hokkaido Dementia Drugs Landscape Analysis
-
6.1 Hokkaido Dementia Drugs Landscape Analysis by Major Types
-
6.2 Hokkaido Dementia Drugs Landscape Analysis by Major End-Users
7 Tohoku Dementia Drugs Landscape Analysis
-
7.1 Tohoku Dementia Drugs Landscape Analysis by Major Types
-
7.2 Tohoku Dementia Drugs Landscape Analysis by Major End-Users
8 Kanto Dementia Drugs Landscape Analysis
-
8.1 Kanto Dementia Drugs Landscape Analysis by Major Types
-
8.2 Kanto Dementia Drugs Landscape Analysis by Major End-Users
9 Chubu Dementia Drugs Landscape Analysis
-
9.1 Chubu Dementia Drugs Landscape Analysis by Major Types
-
9.2 Chubu Dementia Drugs Landscape Analysis by Major End-Users
10 Kinki Dementia Drugs Landscape Analysis
-
10.1 Kinki Dementia Drugs Landscape Analysis by Major Types
-
10.2 Kinki Dementia Drugs Landscape Analysis by Major End-Users
11 Chugoku Dementia Drugs Landscape Analysis
-
11.1 Chugoku Dementia Drugs Landscape Analysis by Major Types
-
11.2 Chugoku Dementia Drugs Landscape Analysis by Major End-Users
12 Shikoku Dementia Drugs Landscape Analysis
-
12.1 Shikoku Dementia Drugs Landscape Analysis by Major Types
-
12.2 Shikoku Dementia Drugs Landscape Analysis by Major End-Users
13 Kyushu Dementia Drugs Landscape Analysis
-
13.1 Kyushu Dementia Drugs Landscape Analysis by Major Types
-
13.2 Kyushu Dementia Drugs Landscape Analysis by Major End-Users
14 Major Players Profiles
14.1 Sanofi SA
14.1.1 Sanofi SA Company Profile and Recent Development
14.1.2 Market Performance
14.1.3 Product and Service Introduction
14.2 Merck & Co, Inc
14.2.1 Merck & Co, Inc Company Profile and Recent Development
14.2.2 Market Performance
14.2.3 Product and Service Introduction
14.3 Janssen Pharmaceuticals, Inc
14.3.1 Janssen Pharmaceuticals, Inc Company Profile and Recent Development
14.3.2 Market Performance
14.3.3 Product and Service Introduction
14.4 Novartis AG
14.4.1 Novartis AG Company Profile and Recent Development
14.4.2 Market Performance
14.4.3 Product and Service Introduction
14.5 Valeant Pharmaceutical International
14.5.1 Valeant Pharmaceutical International Company Profile and Recent Development
14.5.2 Market Performance
14.5.3 Product and Service Introduction
14.6 F. Hoffmann-La Roche
14.6.1 F. Hoffmann-La Roche Company Profile and Recent Development
14.6.2 Market Performance
14.6.3 Product and Service Introduction
14.7 Eli Lilly and Company
14.7.1 Eli Lilly and Company Company Profile and Recent Development
14.7.2 Market Performance
14.7.3 Product and Service Introduction
14.8 Sanofi S.A
14.8.1 Sanofi S.A Company Profile and Recent Development
14.8.2 Market Performance
14.8.3 Product and Service Introduction
14.9 Merck & Co., Inc
14.9.1 Merck & Co., Inc Company Profile and Recent Development
14.9.2 Market Performance
14.9.3 Product and Service Introduction
14.10 AstraZeneca GmbH
14.10.1 AstraZeneca GmbH Company Profile and Recent Development
14.10.2 Market Performance
14.10.3 Product and Service Introduction
14.11 Teva Pharmaceuticals Industries
14.11.1 Teva Pharmaceuticals Industries Company Profile and Recent Development
14.11.2 Market Performance
14.11.3 Product and Service Introduction
14.12 Forest Laboratories, Inc
14.12.1 Forest Laboratories, Inc Company Profile and Recent Development
14.12.2 Market Performance
14.12.3 Product and Service Introduction
14.13 Pfizer Inc
14.13.1 Pfizer Inc Company Profile and Recent Development
14.13.2 Market Performance
14.13.3 Product and Service Introduction
The List of Tables and Figures (Totals 104 Figures and 152 Tables)
Figure Japan Dementia Drugs Market Size and Growth Rate of MAO Inhibitors from 2014 to 2026
Figure Japan Dementia Drugs Market Size and Growth Rate of Cholinesterase Inhibitors from 2014 to 2026
Figure Japan Dementia Drugs Market Size and Growth Rate of Glutamate Inhibitors from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
Figure Japan Dementia Drugs Market Size and Growth Rate of Glutamate Inhibitors from 2014 to 2026
Figure Japan Dementia Drugs Market Size and Growth Rate of Glutamate Inhibitors from 2014 to 2026
Figure Japan Dementia Drugs Market Size and Growth Rate of Glutamate Inhibitors from 2014 to 2026
Figure Japan Dementia Drugs Market Size and Growth Rate of Glutamate Inhibitors from 2014 to 2026
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure Hokkaido Dementia Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Tohoku Dementia Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kanto Dementia Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chubu Dementia Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kinki Dementia Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chugoku Dementia Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Shikoku Dementia Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kyushu Dementia Drugs Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Dementia Drugs Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Dementia Drugs
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Dementia Drugs by Different Types from 2014 to 2026
-
Table Consumption Share of Dementia Drugs by Different Types from 2014 to 2026
Figure Market Size and Growth Rate of MAO Inhibitors
Figure Market Size and Growth Rate of Cholinesterase Inhibitors
Figure Market Size and Growth Rate of Glutamate Inhibitors
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Dementia Drugs by Different End-Users from 2014 to 2026
-
Table Consumption Share of Dementia Drugs by Different End-Users from 2014 to 2026
Figure Japan Dementia Drugs Market Size and Growth Rate of Glutamate Inhibitors from 2014 to 2026
Figure Japan Dementia Drugs Market Size and Growth Rate of Glutamate Inhibitors from 2014 to 2026
Figure Japan Dementia Drugs Market Size and Growth Rate of Glutamate Inhibitors from 2014 to 2026
Figure Japan Dementia Drugs Market Size and Growth Rate of Glutamate Inhibitors from 2014 to 2026
-
Table Japan Dementia Drugs Production by Regions
-
Table Japan Dementia Drugs Production Share by Regions
-
Figure Japan Dementia Drugs Production Share by Regions in 2014
-
Figure Japan Dementia Drugs Production Share by Regions in 2018
-
Figure Japan Dementia Drugs Production Share by Regions in 2026
-
Table Japan Dementia Drugs Consumption by Regions
-
Table Japan Dementia Drugs Consumption Share by Regions
-
Figure Japan Dementia Drugs Consumption Share by Regions in 2014
-
Figure Japan Dementia Drugs Consumption Share by Regions in 2018
-
Figure Japan Dementia Drugs Consumption Share by Regions in 2026
-
Table Hokkaido Dementia Drugs Consumption by Types from 2014 to 2026
-
Table Hokkaido Dementia Drugs Consumption Share by Types from 2014 to 2026
-
Figure Hokkaido Dementia Drugs Consumption Share by Types in 2014
-
Figure Hokkaido Dementia Drugs Consumption Share by Types in 2018
-
Figure Hokkaido Dementia Drugs Consumption Share by Types in 2026
-
Table Hokkaido Dementia Drugs Consumption by End-Users from 2014 to 2026
-
Table Hokkaido Dementia Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Hokkaido Dementia Drugs Consumption Share by End-Users in 2014
-
Figure Hokkaido Dementia Drugs Consumption Share by End-Users in 2018
-
Figure Hokkaido Dementia Drugs Consumption Share by End-Users in 2026
-
Table Tohoku Dementia Drugs Consumption by Types from 2014 to 2026
-
Table Tohoku Dementia Drugs Consumption Share by Types from 2014 to 2026
-
Figure Tohoku Dementia Drugs Consumption Share by Types in 2014
-
Figure Tohoku Dementia Drugs Consumption Share by Types in 2018
-
Figure Tohoku Dementia Drugs Consumption Share by Types in 2026
-
Table Tohoku Dementia Drugs Consumption by End-Users from 2014 to 2026
-
Table Tohoku Dementia Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Tohoku Dementia Drugs Consumption Share by End-Users in 2014
-
Figure Tohoku Dementia Drugs Consumption Share by End-Users in 2018
-
Figure Tohoku Dementia Drugs Consumption Share by End-Users in 2026
-
Table Kanto Dementia Drugs Consumption by Types from 2014 to 2026
-
Table Kanto Dementia Drugs Consumption Share by Types from 2014 to 2026
-
Figure Kanto Dementia Drugs Consumption Share by Types in 2014
-
Figure Kanto Dementia Drugs Consumption Share by Types in 2018
-
Figure Kanto Dementia Drugs Consumption Share by Types in 2026
-
Table Kanto Dementia Drugs Consumption by End-Users from 2014 to 2026
-
Table Kanto Dementia Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Kanto Dementia Drugs Consumption Share by End-Users in 2014
-
Figure Kanto Dementia Drugs Consumption Share by End-Users in 2018
-
Figure Kanto Dementia Drugs Consumption Share by End-Users in 2026
-
Table Chubu Dementia Drugs Consumption by Types from 2014 to 2026
-
Table Chubu Dementia Drugs Consumption Share by Types from 2014 to 2026
-
Figure Chubu Dementia Drugs Consumption Share by Types in 2014
-
Figure Chubu Dementia Drugs Consumption Share by Types in 2018
-
Figure Chubu Dementia Drugs Consumption Share by Types in 2026
-
Table Chubu Dementia Drugs Consumption by End-Users from 2014 to 2026
-
Table Chubu Dementia Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Chubu Dementia Drugs Consumption Share by End-Users in 2014
-
Figure Chubu Dementia Drugs Consumption Share by End-Users in 2018
-
Figure Chubu Dementia Drugs Consumption Share by End-Users in 2026
-
Table Kinki Dementia Drugs Consumption by Types from 2014 to 2026
-
Table Kinki Dementia Drugs Consumption Share by Types from 2014 to 2026
-
Figure Kinki Dementia Drugs Consumption Share by Types in 2014
-
Figure Kinki Dementia Drugs Consumption Share by Types in 2018
-
Figure Kinki Dementia Drugs Consumption Share by Types in 2026
-
Table Kinki Dementia Drugs Consumption by End-Users from 2014 to 2026
-
Table Kinki Dementia Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Kinki Dementia Drugs Consumption Share by End-Users in 2014
-
Figure Kinki Dementia Drugs Consumption Share by End-Users in 2018
-
Figure Kinki Dementia Drugs Consumption Share by End-Users in 2026
-
Table Chugoku Dementia Drugs Consumption by Types from 2014 to 2026
-
Table Chugoku Dementia Drugs Consumption Share by Types from 2014 to 2026
-
Figure Chugoku Dementia Drugs Consumption Share by Types in 2014
-
Figure Chugoku Dementia Drugs Consumption Share by Types in 2018
-
Figure Chugoku Dementia Drugs Consumption Share by Types in 2026
-
Table Chugoku Dementia Drugs Consumption by End-Users from 2014 to 2026
-
Table Chugoku Dementia Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Chugoku Dementia Drugs Consumption Share by End-Users in 2014
-
Figure Chugoku Dementia Drugs Consumption Share by End-Users in 2018
-
Figure Chugoku Dementia Drugs Consumption Share by End-Users in 2026
-
Table Shikoku Dementia Drugs Consumption by Types from 2014 to 2026
-
Table Shikoku Dementia Drugs Consumption Share by Types from 2014 to 2026
-
Figure Shikoku Dementia Drugs Consumption Share by Types in 2014
-
Figure Shikoku Dementia Drugs Consumption Share by Types in 2018
-
Figure Shikoku Dementia Drugs Consumption Share by Types in 2026
-
Table Shikoku Dementia Drugs Consumption by End-Users from 2014 to 2026
-
Table Shikoku Dementia Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Shikoku Dementia Drugs Consumption Share by End-Users in 2014
-
Figure Shikoku Dementia Drugs Consumption Share by End-Users in 2018
-
Figure Shikoku Dementia Drugs Consumption Share by End-Users in 2026
-
Table Kyushu Dementia Drugs Consumption by Types from 2014 to 2026
-
Table Kyushu Dementia Drugs Consumption Share by Types from 2014 to 2026
-
Figure Kyushu Dementia Drugs Consumption Share by Types in 2014
-
Figure Kyushu Dementia Drugs Consumption Share by Types in 2018
-
Figure Kyushu Dementia Drugs Consumption Share by Types in 2026
-
Table Kyushu Dementia Drugs Consumption by End-Users from 2014 to 2026
-
Table Kyushu Dementia Drugs Consumption Share by End-Users from 2014 to 2026
-
Figure Kyushu Dementia Drugs Consumption Share by End-Users in 2014
-
Figure Kyushu Dementia Drugs Consumption Share by End-Users in 2018
-
Figure Kyushu Dementia Drugs Consumption Share by End-Users in 2026
Table Company Profile and Development Status of Sanofi SA
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi SA
Figure Sales and Growth Rate Analysis of Sanofi SA
Figure Revenue and Market Share Analysis of Sanofi SA
Table Product and Service Introduction of Sanofi SA
Table Company Profile and Development Status of Merck & Co, Inc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co, Inc
Figure Sales and Growth Rate Analysis of Merck & Co, Inc
Figure Revenue and Market Share Analysis of Merck & Co, Inc
Table Product and Service Introduction of Merck & Co, Inc
Table Company Profile and Development Status of Janssen Pharmaceuticals, Inc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Janssen Pharmaceuticals, Inc
Figure Sales and Growth Rate Analysis of Janssen Pharmaceuticals, Inc
Figure Revenue and Market Share Analysis of Janssen Pharmaceuticals, Inc
Table Product and Service Introduction of Janssen Pharmaceuticals, Inc
Table Company Profile and Development Status of Novartis AG
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG
Figure Sales and Growth Rate Analysis of Novartis AG
Figure Revenue and Market Share Analysis of Novartis AG
Table Product and Service Introduction of Novartis AG
Table Company Profile and Development Status of Valeant Pharmaceutical International
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Valeant Pharmaceutical International
Figure Sales and Growth Rate Analysis of Valeant Pharmaceutical International
Figure Revenue and Market Share Analysis of Valeant Pharmaceutical International
Table Product and Service Introduction of Valeant Pharmaceutical International
Table Company Profile and Development Status of F. Hoffmann-La Roche
Table Sales, Revenue, Sales Price and Gross Margin Analysis of F. Hoffmann-La Roche
Figure Sales and Growth Rate Analysis of F. Hoffmann-La Roche
Figure Revenue and Market Share Analysis of F. Hoffmann-La Roche
Table Product and Service Introduction of F. Hoffmann-La Roche
Table Company Profile and Development Status of Eli Lilly and Company
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly and Company
Figure Sales and Growth Rate Analysis of Eli Lilly and Company
Figure Revenue and Market Share Analysis of Eli Lilly and Company
Table Product and Service Introduction of Eli Lilly and Company
Table Company Profile and Development Status of Sanofi S.A
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi S.A
Figure Sales and Growth Rate Analysis of Sanofi S.A
Figure Revenue and Market Share Analysis of Sanofi S.A
Table Product and Service Introduction of Sanofi S.A
Table Company Profile and Development Status of Merck & Co., Inc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co., Inc
Figure Sales and Growth Rate Analysis of Merck & Co., Inc
Figure Revenue and Market Share Analysis of Merck & Co., Inc
Table Product and Service Introduction of Merck & Co., Inc
Table Company Profile and Development Status of AstraZeneca GmbH
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca GmbH
Figure Sales and Growth Rate Analysis of AstraZeneca GmbH
Figure Revenue and Market Share Analysis of AstraZeneca GmbH
Table Product and Service Introduction of AstraZeneca GmbH
Table Company Profile and Development Status of Teva Pharmaceuticals Industries
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceuticals Industries
Figure Sales and Growth Rate Analysis of Teva Pharmaceuticals Industries
Figure Revenue and Market Share Analysis of Teva Pharmaceuticals Industries
Table Product and Service Introduction of Teva Pharmaceuticals Industries
Table Company Profile and Development Status of Forest Laboratories, Inc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Forest Laboratories, Inc
Figure Sales and Growth Rate Analysis of Forest Laboratories, Inc
Figure Revenue and Market Share Analysis of Forest Laboratories, Inc
Table Product and Service Introduction of Forest Laboratories, Inc
Table Company Profile and Development Status of Pfizer Inc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer Inc
Figure Sales and Growth Rate Analysis of Pfizer Inc
Figure Revenue and Market Share Analysis of Pfizer Inc
Table Product and Service Introduction of Pfizer Inc
-
